Prosecution Insights
Last updated: October 27, 2026
Application No. 18/780,274

HEMODIALYSIS SYSTEMS AND METHODS

Non-Final OA §112
Filed
Jul 22, 2024
Priority
Feb 27, 2007 — provisional 60/903,582 +8 more
Examiner
KIM, SUN U
Art Unit
1772
Tech Center
1700 — Chemical & Materials Engineering
Assignee
DEKA Products Limited Partnership
OA Round
1 (Non-Final)
78%
Grant Probability
Favorable
1-2
OA Rounds
6m
Est. Remaining
90%
With Interview

Examiner Intelligence

Grants 78% — above average
78%
Career Allowance Rate
772 granted / 987 resolved
+13.2% vs TC avg
Moderate +12% lift
Without
With
+11.6%
Interview Lift
resolved cases with interview
Typical timeline
2y 9m
Avg Prosecution
50 currently pending
Career history
1031
Total Applications
across all art units

Statute-Specific Performance

§101
1.5%
-38.5% vs TC avg
§103
44.9%
+4.9% vs TC avg
§102
24.0%
-16.0% vs TC avg
§112
19.3%
-20.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 987 resolved cases

Office Action

§112
Notice of Pre-AIA or AIA Status The present application is being examined under the pre-AIA first to invent provisions. Specification Examiner suggests applicant to update the status of parent U.S. Patent Application No. 18/452,516 as follows: Under “RELATED APPLICATIONS” in Page 1: -Line 2: After “2023, ”, add “and issued as U.S. Patent No. 12,064,540, “. Claim Objections Claims 14 and 22-23 are objected to because of the following informalities: -Claim 14, Line 10: Recitation of “(500)” should be deleted. -Claim 22, Line 2: “pumps” should be changed to “is configured to pump”. -Claim 23, Line 2: “pumps” should be changed to “is configured to pump”. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 4 and 14 are rejected under 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 4 recites the limitation "the drain path" in line 23. There is insufficient antecedent basis for this limitation in the claim. Claim 14 recites the limitation "the second flowpath" in line 4. There is insufficient antecedent basis for this limitation in the claim. Allowable Subject Matter Claim 4 would be allowable if rewritten or amended to overcome the rejection(s) under 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action. Claim 14 would be allowable if rewritten to overcome the rejection(s) under 35 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action and to include all of the limitations of the base claim and any intervening claims. Claims 5-13 and 15-23 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: Connell et al (US 2005/0242034 A1) is considered the closest prior art to a hemodialysis system of claim 4. Connell et al teach a hemodialysis system comprising: a blood flow path (308, 310) through which blood is drawn from a patient and passed through a dialyzer (306); and a dialysate flow path (206, 174) through which dialysate flows from a dialysate supply through the dialyzer (306), the dialysate flow path comprising: a balancing fluid circuit (54, 42, 72) which controls the amount of dialysate passing through the dialyzer, a mixing fluid circuit (121, 124, 38, 40, 88, 112) which forms dialysate from dialysate precursor and water, and a directing fluid circuit (82, 86, 24) which passes water from a water supply to the mixing fluid circuit and passes dialysate from the mixing fluid circuit to the balancing fluid circuit (see figures 1A-1B, 6-7; paragraphs 00170054, 0065, 0111, 0141-0149). Connell et al. further teaches a dialysate conductivity sensor (60) (see fig. 1B), a conductivity sensor (46) (see fig. 1B), two reciprocating positive displacement pumps (42, 72) (see fig. 1A-1B), a dialysate reservoir (26) (see fig. 1A), acid concentrate (88) (see fig. 1A; paragraph 0022) and bicarbonate concentrate (112) (see fig. 1B; paragraph 0033). Tracey et al (US 2008/0175719 A1) teach a cassette system (2015) comprising pod pumps (2025)(see figure 22A; paragraphs 0250, 0261, 0346). Donig et al (US Patent No. 6,743,201) teach a cassette (10) for delivering fluids which have the advantages of partial functions of delivering, metering/balancing, mixing, measuring, connecting and heating of medical fluids can be combined and performed in one unit to greatly facilitate operation of the system and make it more fail-safe by minimizing the steps that are subject to the risk (see figure 1; col. 1, lines 49-57). However, none of the prior art of record teaches or suggests the hemodialysis system comprising: the mixing fluid circuit comprising a mixing cassette including a fluid flowpath for mixing water with bicarbonate solution to form water and bicarbonate mixture, and for mixing water and bicarbonate mixture with acid solution to form dialysate; the mixing cassette configured to: send a volume of bicarbonate and water mixture to an external sensor cassette, and receive the volume of bicarbonate and water mixture from the sensor cassette; mix the volume of bicarbonate and water mixture with acid solution to form a volume of dialysate if the volume of bicarbonate and water mixture meets a first conductivity threshold or parameter in the sensor cassette; send the volume of dialysate to the sensor cassette, and receive the volume of dialysate from the sensor cassette; send the volume of dialysate to a drain path if the volume of dialysate does not meet a second conductivity threshold or parameter measured in the sensor cassette; and send the volume of dialysate to an external dialysate reservoir if the volume of dialysate meets a second conductivity threshold or parameter in the sensor cassette. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOHN KIM whose telephone number is (571)272-1142. The examiner can normally be reached Maxi Flex. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, INSUK BULLOCK can be reached at 571-272-5954. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /John Kim/Primary Examiner, Art Unit 1772 JK 9/24/26
Read full office action

Prosecution Timeline

Jul 22, 2024
Application Filed
Sep 28, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12758695
WEARABLE AUTOMATED PERITONEAL DIALYSIS DEVICE
3y 8m to grant Granted Oct 13, 2026
Patent 12758694
DIALYSIS SYSTEM HAVING PUMP REVERSING DISINFECTION
3y 1m to grant Granted Oct 13, 2026
Patent 12758690
WEARABLE BREAST PUMP
2y 10m to grant Granted Oct 13, 2026
Patent 12758696
AUTOMATED PERITONEAL DIALYSIS DEVICE, SYSTEM AND METHOD OF CUSTOMIZING DIALYSATE SOLUTIONS
2y 6m to grant Granted Oct 13, 2026
Patent 12746313
PERITONEAL DIALYSIS CYCLER USING MICROPUMP
3y 8m to grant Granted Sep 29, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
78%
Grant Probability
90%
With Interview (+11.6%)
2y 9m (~6m remaining)
Median Time to Grant
Low
PTA Risk
Based on 987 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month